MONTELEONE, Palmiero
 Distribuzione geografica
Continente #
NA - Nord America 27.152
AS - Asia 12.610
EU - Europa 7.475
SA - Sud America 1.026
AF - Africa 72
Continente sconosciuto - Info sul continente non disponibili 36
OC - Oceania 32
Totale 48.403
Nazione #
US - Stati Uniti d'America 26.984
HK - Hong Kong 5.536
SG - Singapore 2.394
CN - Cina 2.174
UA - Ucraina 2.088
IT - Italia 1.747
DE - Germania 863
BR - Brasile 859
VN - Vietnam 827
TR - Turchia 754
RU - Federazione Russa 645
IE - Irlanda 611
KR - Corea 487
FI - Finlandia 472
SE - Svezia 472
IN - India 207
GB - Regno Unito 124
FR - Francia 107
CA - Canada 82
AR - Argentina 67
AT - Austria 62
MX - Messico 48
PL - Polonia 41
JP - Giappone 40
NL - Olanda 36
EC - Ecuador 35
EU - Europa 35
ES - Italia 33
BD - Bangladesh 25
ID - Indonesia 24
AU - Australia 23
BE - Belgio 23
IQ - Iraq 21
CZ - Repubblica Ceca 18
RO - Romania 15
ZA - Sudafrica 15
BG - Bulgaria 14
CH - Svizzera 14
PE - Perù 14
UZ - Uzbekistan 13
VE - Venezuela 13
IL - Israele 11
JO - Giordania 11
LT - Lituania 11
NP - Nepal 11
CL - Cile 9
EG - Egitto 9
NZ - Nuova Zelanda 9
AE - Emirati Arabi Uniti 8
HR - Croazia 8
HU - Ungheria 8
IR - Iran 8
PK - Pakistan 8
PY - Paraguay 8
GR - Grecia 7
MA - Marocco 7
MY - Malesia 7
NO - Norvegia 7
UY - Uruguay 7
CO - Colombia 6
DO - Repubblica Dominicana 6
RS - Serbia 6
BN - Brunei Darussalam 5
BO - Bolivia 5
KE - Kenya 5
PT - Portogallo 5
SA - Arabia Saudita 5
TN - Tunisia 5
AL - Albania 4
AZ - Azerbaigian 4
BA - Bosnia-Erzegovina 4
DZ - Algeria 4
ET - Etiopia 4
GT - Guatemala 4
LU - Lussemburgo 4
MD - Moldavia 4
MK - Macedonia 4
SN - Senegal 4
SV - El Salvador 4
TW - Taiwan 4
GH - Ghana 3
IM - Isola di Man 3
JM - Giamaica 3
MN - Mongolia 3
PS - Palestinian Territory 3
AF - Afghanistan, Repubblica islamica di 2
AM - Armenia 2
AO - Angola 2
BB - Barbados 2
CR - Costa Rica 2
DK - Danimarca 2
EE - Estonia 2
GL - Groenlandia 2
GY - Guiana 2
HN - Honduras 2
KG - Kirghizistan 2
LB - Libano 2
LC - Santa Lucia 2
LI - Liechtenstein 2
LV - Lettonia 2
Totale 48.357
Città #
Ann Arbor 6.775
Hong Kong 5.525
Woodbridge 2.664
Jacksonville 2.555
Wilmington 2.306
Chandler 2.161
Princeton 1.910
Houston 1.709
Dallas 1.096
Ashburn 831
Izmir 728
Singapore 612
Dong Ket 610
Dublin 608
Nanjing 509
Andover 481
Boardman 363
Pellezzano 338
Beijing 299
Düsseldorf 241
Moscow 241
Hebei 178
Fairfield 169
Naples 167
Shenyang 167
Pune 163
Norwalk 162
Mestre 160
Nanchang 157
Changsha 127
Jiaxing 118
Los Angeles 114
Seattle 83
Ho Chi Minh City 81
Salerno 80
Tianjin 75
Washington 71
São Paulo 70
Redwood City 67
Milan 64
Munich 62
New York 57
Council Bluffs 53
Rome 52
San Nicola la Strada 50
Hanoi 49
Des Moines 46
Nuremberg 46
The Dalles 43
San Diego 41
Brooklyn 34
Edinburgh 34
Warsaw 34
Rio de Janeiro 33
Santa Clara 32
Cambridge 31
Belo Horizonte 29
San Francisco 28
Tokyo 28
Boston 27
Chicago 27
Dearborn 27
Nettuno 27
Columbus 24
Jinan 23
Sant'Anastasia 23
Vienna 22
Atlanta 21
Brussels 20
Florence 19
Shanghai 19
Stockholm 18
Amsterdam 17
Montreal 17
Turin 17
Boydton 16
Falconara Marittima 16
Guangzhou 16
Guayaquil 16
Ottawa 16
Turku 16
London 15
Toronto 15
Venezia 15
Brasília 14
Catania 14
Lappeenranta 14
Baghdad 13
Curitiba 13
Da Nang 13
Tashkent 13
Benevento 12
Cardito 12
Frankfurt am Main 12
Madrid 12
Paris 12
Phoenix 12
Quito 12
Sydney 12
Wuhan 12
Totale 36.308
Nome #
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders. 1.247
Early traumatic experiences and eating disorders: A focus on the endogenous stress response system 602
Circadian rhythms and treatment implications in depression 446
Assenza di modulazione GABAergica sulla secrezione basale di prolattina e di GH nella schizofrenia cronica 443
No association of the Arg51Gln and Leu72Met polymorphisms of the ghrelin gene with anorexia nervosa or bulimia nervosa 421
Enhanced response of ghrelin to sham feeding in patients with anorexia nervosa 410
Lowered serum dipeptidyl peptidase IV activity in patients with anorexia and bulimia nervosa 336
Accuracy of self-assessment of real-life functioning in schizophrenia 330
Ghrelin response to hedonic eating in underweight and short-term weight restored patients with anorexia nervosa 318
Significant Locus and Metabolic Genetic Correlations Revealed in Genome-Wide Association Study of Anorexia Nervosa 299
Health-related quality of life in euthymic bipolar disorder patients: Differences between bipolar I and II subtypes 234
Circulating levels of neuroactive steroids in patients with binge eating disorder: a comparison with nonobese healthy controls and non-binge eating obese subjects 218
Serotonin transporter polymorphism and potential response to SSRIs in bulimia nervosa. 210
Physical exercise at night blunts the nocturnal increase of plasma melatonin levels in healthy humans 202
Melanocortin-4 receptor molecular scanning and pro-opiomelanocortin R236G variant screening in binge eating disorder 195
Mismatch Negativity and P3a Impairment through Different Phases of Schizophrenia and Their Association with Real-Life Functioning 190
Appropriatezza clinica, strutturale e operativa nella prevenzione, diagnosi e terapia dei disturbi dell’alimentazione 185
Childhood trauma and cortisol awakening response in symptomatic patients with anorexia nervosa and bulimia nervosa 169
The human pineal gland responds to stress-induced sympathetic activation in the second half of the dark phase: preliminary evidence 160
A 4-year epidemiological study of typical and atypical eating disorders: preliminary evidence for subgroups of atypical eating disorders with different natural outcomes 157
Altered processing of rewarding and aversive basic taste stimuli in symptomatic women with anorexia nervosa and bulimia nervosa: An fMRI study 157
An epidemiological study on eating disorders in two high schools in Naples 153
Lateralization patterns of verbal stimuli processing assessed by reaction time and event-related potentials in schizophrenic patients 146
Leptin secretion is related to chronicity and severity of the illness in bulimia nervosa 146
Altered immunoreactive levels of G proteins in peripheral mononuclear cells of patients with anorexia nervosa and bulimia nervosa 144
Deranged endocannabinoid responses to hedonic eating in underweight and recently weight-restored patients with anorexia nervosa 143
Serotonergic modulation of rat pineal gland activity: in vivo evidence for a 5-Hydroxytryptamine(2C) receptor involvement 142
3111T/C polymorphism of the clock gene confers a predisposition to a lifetime lower body weight in anorexia and bulimia nervosa 141
Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: evidence for synergistic effects 138
Differences between morning and afternoon hormonal responses to D-fenfluramine in healthy humans 136
Regolazione del comportamento alimentare e correlati biochimici dell’anoressia e bulimia nervosa 135
The 196G/A (val66met) polymorphism of the BDNF gene is significantly associated with binge eating behavior in women with bulimia nervosa or binge eating disorder 133
Serotonin Trasporter Polymorphisms And Ssri Response In Bulimia Nervosa 130
Evidence that cholinergic receptors of muscarinic type may modulate vasopressin release induced by metoclopramide 130
Growth hormone response to GABA?B receptor activation in depressed patients before and after antidepressant therapy 127
Aggressive behavioral characteristics and endogenous hormones in women with Bulimia nervosa 127
Correlations between negative symptoms and peripheral G protein levels in mononuclear leukocytes of deficit and nondeficit schizophrenics. Preliminary results 127
Alterazioni neuroendocrine nella depressione stagionale 126
Aripiprazole augmentation strategy in clomipramine-resistant depressive patients: an open preliminary study. 125
Plasma concentrations of amino acids in chronic schizophrenics treated with clozapine 125
The treatment of unipolar depression by lithium salts 124
Naloxone-induced decrease of plasma prolactin in healthy women 124
Evidence for opiate and estrogen interaction on neurohormonal secretion 124
Melatonin and cortisol secretion in patients with primary obsessive-compulsive disorder 124
Neuroendocrine effect of short term activation of GABAergic system in schizophrenics with and without tardive dyskinesia 123
The circadian basis of mood disorders: Recent developments and treatment implications 123
Cortisol response to d-fenfluramine in patients with obsessive-compulsive disorder and in healthy subjects: evidence for a gender-related effect 123
Chronic antidepressant drug treatment does not affect GH response to baclofen in depressed subjects 123
(+)-N-allylnormetazocine enhances N-acetyltransferase activity and melatonin synthesis: preliminary evidence for a functional role of sigma receptors in the rat pineal gland 123
Baclofen-induced growth hormone secretion is blunted in chronic schizophrenics: neuroendocrine evidence for a GABA disturbance in schizophrenia 122
A comparative study of melatonin production in the retina, pineal gland and harderian gland of Bufo viridis and Rana esculenta 122
Combined alpha-adrenergic stimulation results in biphasic response of growth hormone release in man 121
The family of a patient with an eating disorder 121
Underweight subjects with anorexia nervosa have an enhanced salivary cortisol response not seen in weight restored subjects with anorexia nervosa 121
Are antipsychotics useful in the treatment of anorexia nervosa? 120
NEUROENDOCRINOLOGY OF EATING DISORDERS: RECENT ADVANCES AND FUTURE PERSPECTIVES 120
Psychobiology of eating disorders 120
Brain-derived neurtrophic factor in mood disorders: reply to Kapczinski et al.’s comment 120
The acute salivary ghrelin response to a psychosocial stress is enhanced in symptomatic patients with bulimia nervosa: a pilot study. 118
Effect of pharmacological activation of gamma?aminobutyric acid system on basal pituitary secretion in humans 117
Association between A218C polymorphism of the tryptophan-hydroxylase-1 gene, harm avoidance and binge eating behavior in bulimia nervosa 116
[Evaluation of therapeutic efficacy and pharmacokinetics of controlled release of trazodone in patients with major depressive disorder] 116
Asymmetry of salivary cortisol and α-amylase responses to psychosocial stress in anorexia nervosa but not in bulimia nervosa 115
Impulsiveness in patients with bulimia nervosa: electrophysiological evidence of reduced inhibitory control. 115
Psicobiologia dei disturbi del comportamento alimentare 115
Effects of single and repeated electroconvulsive shock on isoproterenol-stimulated pineal N-acetyltransferase activity and melatonin production in rats 114
Assessment of Response to Lithium Maintenance Treatment in Bipolar Disorder: A Consortium on Lithium Genetics (ConLiGen) Report. 114
Responses of peripheral endocannabinoids and endocannabinoid-related compounds to hedonic eating in obesity 114
Circulating ghrelin is decreased in non-obese and obese women with binge eating disorder as well as in obese non-binge eating women, but not in patients with bulimia nervosa 113
Self-injurious behavior and attempted suicide in purging bulimia nervosa: Associations with psychiatric comorbidity 113
Risposta della prolattina alla d-fenfluramina in pazienti con sindrome ossessivo-compulsiva prima e dopo terapia con fluvoxamina 113
Circadian Rhythm disturbances in depression: implications for treatment and quality of remission 112
Pharmacological activation of the GABAergic system does not affect GH and PRL release in acromegaly 112
Association of a functional serotonin transporter gene polymorphism with binge eating disorder 112
PERIPHERAL NEUROSTEROID CONCENTRATIONS IN EATING DISORDERS 111
Differences in Cortisol Awakening Response between Binge-Purging and Restrictive Patients with Anorexia Nervosa 111
Interhemispheric functional connectivity in anorexia and bulimia nervosa 111
Biological background of the psychological effects of cognitive-behavioural therapy in anorexia nervosa 110
Development and validation of the family coping questionnaire for eating disorders 110
Suppression of nocturnal plasma melatonin levels by evening administration of sodium valproate in healthy humans 110
Leptin functioning in eating disorders 110
PLASMA LEPTIN AND WEIGHT GAIN DURINO CLOZAPINE TREATMENT 110
Interplay among psychopathologic variables, personal resources, context-related factors, and real-life functioning in individuals with schizophrenia a network analysis 110
Plasma melatonin and cortisol circadian patterns in patients with obsessive-compulsive disorder before and after fluoxetine treatment 109
Changes in magnocellular neurosecretory activity following septal forebrain lesions: morphological and biochemical data 108
Investigation of the serotonin transporter regulatory region polymorphism in bulimia nervosa: relationships to harm avoidance, nutritional parameters, and psychiatric comorbidity 108
Decreased nocturnal secretion of melatonin in drug-free schizophrenics: no change after subchronic treatment with antipsychotics 108
G-PROTEIN IMMUNOREACTIVITY LEVELS IN LYMPHOCYTES OF DEFICIT AND NONDEFICIT SCHIZOPHRENIC PATIENTS 108
Brain-derived neurotrophic factor (BDNF) and eating behaviour in bulimia nervosa and binge eating disorder 108
Blood levels of mianserin and amitriptyline and clinical response in aged depressed patients 108
Immunoendocrine findings in patients with eating disorders 107
Seasonal variation in plasma prolactin response to D-fenfluramine in healthy subjects 107
The Brief Negative Symptom Scale (BNSS): Independent validation in a large sample of Italian patients with schizophrenia 107
INVESTIGATION OF NEUROACTIVE STEROIDS IN ANOREXIA AND BULIMIA NERVOSA 106
Plamsa leptin response to acute fasting and refeeding in untreated women with bulimia nervosa 106
Opposite changes in circulating adiponectin in women with bulimia nervosa or binge eating disorder 106
Blunting by chronic phosphatidylserine administration of the stress-induced activation of the hypothalamo-pituitary-adrenal axis in healthy men 106
How do relatives cope with eating disorders? Results from an Italian multicentre study 106
Role of seizure activity in the decreased pineal response to isoproterenol in rats chronically treated with electroconvulsive shock 106
Leptin production in bulimia nervosa 105
Totale 16.342
Categoria #
all - tutte 170.193
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 170.193


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.955 0 0 0 0 495 189 462 69 453 30 483 774
2021/20223.332 9 4 18 29 36 22 50 129 517 439 445 1.634
2022/20235.458 616 249 224 479 786 1.162 23 607 737 39 405 131
2023/20242.575 226 332 174 78 153 420 147 241 42 158 201 403
2024/20254.338 328 78 131 148 164 561 610 704 672 194 355 393
2025/20269.142 1.384 2.949 3.484 666 659 0 0 0 0 0 0 0
Totale 49.580